pre 084 has been researched along with sm 346 in 2 studies
| Studies (pre 084) | Trials (pre 084) | Recent Studies (post-2010) (pre 084) | Studies (sm 346) | Trials (sm 346) | Recent Studies (post-2010) (sm 346) |
|---|---|---|---|---|---|
| 116 | 0 | 73 | 129 | 8 | 57 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadnikov, IA; Seredenin, SB; Voronin, MV; Voronkov, DN | 1 |
| Kadnikov, IA; Seredenin, SB; Verbovaya, ER; Voronin, MV; Voronkov, DN | 1 |
2 other study(ies) available for pre 084 and sm 346
| Article | Year |
|---|---|
Chaperone Sigma1R mediates the neuroprotective action of afobazole in the 6-OHDA model of Parkinson's disease.
Topics: Animals; Benzimidazoles; Corpus Striatum; Disease Models, Animal; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Neurons; Neuroprotection; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Receptors, sigma; Rotarod Performance Test; Sigma-1 Receptor; Substantia Nigra | 2019 |
Deferred Administration of Afobazole Induces Sigma1R-Dependent Restoration of Striatal Dopamine Content in a Mouse Model of Parkinson's Disease.
Topics: Animals; Benzimidazoles; Corpus Striatum; Dopamine; Ethylenediamines; Male; Mice; Mice, Inbred ICR; Morpholines; Movement; Parkinson Disease; Receptors, sigma; Sigma-1 Receptor | 2020 |